Bayer Aktiengesellschaft Stock Other OTC
Equities
BAYRY
US0727303028
Pharmaceuticals
Sales 2024 * | 47.09B 50.67B | Sales 2025 * | 47.95B 51.6B | Capitalization | 27.53B 29.62B |
---|---|---|---|---|---|
Net income 2024 * | 2.08B 2.24B | Net income 2025 * | 3.17B 3.41B | EV / Sales 2024 * | 1.29 x |
Net Debt 2024 * | 33.1B 35.62B | Net Debt 2025 * | 29.67B 31.93B | EV / Sales 2025 * | 1.19 x |
P/E ratio 2024 * |
12.8
x | P/E ratio 2025 * |
8.62
x | Employees | - |
Yield 2024 * |
0.39% | Yield 2025 * |
0.83% | Free-Float | 99.97% |
Latest transcript on Bayer Aktiengesellschaft
Managers | Title | Age | Since |
---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
Director of Finance/CFO | 55 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
Paul Achleitner
BRD | Director/Board Member | 67 | 02-03-31 |
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |